INTRODUCTION
============

The induction of deep vein thrombosis (DVT) following total knee arthroplasties (TKAs) and total hip arthroplasties is frequently studied ([@b1-cln_67p1053]), although DVT also results from other knee procedures ([@b2-cln_67p1053]). Despite the importance of and interest in this problem, most researchers studying DVT generally focus on postoperative prophylaxis. Surprisingly, few studies have investigated the isolated risk factors for DVT associated with TKA. Although controversy exists regarding the role of TKA alone as a risk factor for DVT ([@b3-cln_67p1053])--([@b7-cln_67p1053]), some researchers believe that bone manipulation, reaming of the medullary canal, and the operative time are relevant risk factors for DVT ([@b8-cln_67p1053],[@b9-cln_67p1053]). Another important and controversial factor related to TKA is the use of surgical tourniquets. Although all of these factors are mentioned in the literature, operative time has received little attention as an isolated risk factor for DVT in TKA.

We used ascending venography (AV) to determine the presence of proximal and distal DVT after TKA and evaluated the association between tourniquet time and TKA operative time and the occurrence of DVT.

PATIENTS AND METHODS
====================

Seventy-eight consecutive patients from our institution underwent cemented TKA for degenerative knee disorders. Of the 78 patients, 78.2% were women and 21.8% were men, with an average age of 65.1 years (range, 31--88 years; SD, 11.5 years). Osteoarthrosis was the diagnosis in 74.4% of the cases, rheumatoid arthritis in 21.8%, and other disorders in the remaining 3.8%.

All total knee arthroplasties were performed with the same technique. An intramedullary guide was used for distal femoral osteotomy. An extramedullary guide was used for proximal tibial osteotomy. We recorded the total pneumatic tourniquet time and total operative time in minutes. In all cases, the use of a tourniquet was interrupted for hemostasis after the implant was cemented and before wound closure. Four categories were established for total tourniquet time: \<60, 61 to 90, 91 to 120, and \>120 minutes. The total operative time was consistently defined as the time from the initial incision to the last suture stitch made to close the incision. Three categories were defined for operative time: \<120, 121 to 150, and \>150 minutes. Only two patients (3.1%) were administered a general anesthetic; all other patients received a spinal block. All patients received DVT prophylaxis with oral anticoagulants for 12 days, with an international normalized ratio maintained at approximately 2.5 (range, 2.0--3.0) in all cases ([@b10-cln_67p1053]).

An ascending venography, for which the patients provided informed consent, was performed between 7 and 12 days after surgery after discharge from the hospital. The study end point was defined based on the execution of bilateral AV. The AV was performed by a specialist in vascular radiology. The technique applied was performed essentially as described by Rabinov and Paulin ([@b11-cln_67p1053]). The presence of clinically manifested DVT and/or pulmonary embolism was also considered. The clinical manifestations of DVT were defined as follows: greater edema of the affected lower limb than would be expected for the procedure, intense pain on palpation of the calf, and pain on passive dorsiflexion of the foot. An AV finding that was considered to be positive for DVT was the presence of blood clots in the vein lumens ([Figure 1](#f1-cln_67p1053){ref-type="fig"}). DVTs were characterized as occurring on the operated side, on the contralateral side or bilaterally and were classified as proximal or distal DVT.

We used the chi-squared test for the comparison of qualitative variables between groups. For the quantitative variables, we used Levene\'s test to determine the homogeneity of variances and the Kolmogorov-Smirnov test to determine the normality of the distribution. In cases in which both conditions were met, the averages of both groups were compared using Student\'s *t*-test. A level of significance of 5% was adopted in the analyses. The statistical program used was SPSS (SPSS for Windows, release 6.0, SPSS Inc., Chicago, IL, USA).

RESULTS
=======

We found that 45 patients (57.7%) had negative bilateral AV, and 33 (42.3%) had DVT. Thirteen patients (16.7%) had a proximal DVT. We compared the patients with DVT with those without DVT. We also compared the cases with proximal DVT with the cases involving distal DVT and the cases with normal findings on AV.

The baseline characteristics of our patients are summarized in [Table 1](#t1-cln_67p1053){ref-type="table"}. We observed that patients with DVT were older than patients without DVT (62.9±12.3 *vs* 68.2±9.7 years, respectively; *p* = 0.04). When we compared only the patients with proximal DVT with the other patients, we found no difference in age between the groups (64.3±12.0 *vs* 69.2±7.8 years, respectively; *p* = 0.2). We also observed that osteoarthritis was the most frequent diagnosis and was found in almost 90% of patients with DVT.

The total population did not demonstrate any statically significant differences in tourniquet or total operative time based on the presence or absence of DVT, as shown in [Table 2](#t2-cln_67p1053){ref-type="table"}. Considering only patients with proximal DVT, we found no significant difference in tourniquet time (*p* = 0.08). For total operative time, we observed a significant difference between the groups, with a higher frequency of proximal DVT in patients with an operative time that was longer than 120 minutes (*p* = 0.05) ([Table 3](#t3-cln_67p1053){ref-type="table"}). Patients with proximal DVT also had a higher mean operative time (146.9±20.4 *vs* 127.9±22.4 min, respectively; *p* = 0.01) ([Table 4](#t4-cln_67p1053){ref-type="table"}).

DISCUSSION
==========

The systematic reviews of DVT in TKA almost exclusively address therapeutic alternatives for this condition ([@b12-cln_67p1053])--([@b15-cln_67p1053]); few reviews address the risk factors. We believe that undergoing TKA is itself a risk factor for DVT ([@b3-cln_67p1053])--([@b5-cln_67p1053]). One of the few reports that contradict this hypothesis is a report by Fowkes et al. ([@b18-cln_67p1053]), which addresses the general aspects of the incidence of DVT, reporting it as approximately 10,000 persons/year in the general population. Bhandari et al. ([@b19-cln_67p1053]) warned that the inherent limitations of those studies and the lack of attention to other risk factors render these reports of limited value. Gross et al. ([@b20-cln_67p1053]) noted that studies on DVT prophylaxis have demonstrated a low incidence of DVT complications after total hip arthroplasty and TKA, which is far below the incidences that were initially reported in venography studies conducted to detect asymptomatic DVT. Improving the techniques used in perioperative orthopedic care should reduce thromboembolic complications, regardless of prophylaxis. According to Bergqvist et al. ([@b1-cln_67p1053]), the incidence of DVT is higher after TKA than after total hip arthroplasty.

Although many authors accept the possibility of DVT with these procedures, others no longer consider this complication to be a serious problem ([@b21-cln_67p1053],[@b22-cln_67p1053]). Some authors believe that mechanical prophylaxis, even with limited resources, is adequate in all cases of TKA ([@b23-cln_67p1053])--([@b25-cln_67p1053]), whereas others believe that pharmacologic prophylaxis in arthroplasty is indicated in select cases according to the individual risk for DVT ([@b26-cln_67p1053]). We agree with the view of Haas et al. ([@b14-cln_67p1053]); although there is no ideal prophylaxis, a multimodal approach that combines pharmacologic therapy with mechanical prophylaxis has proven to be safe and effective.

The number of studies that clearly define the risk factors for DVT in TKA remains small. Surgical and orthopedic aspects, such as the duration of tourniquet use and operative time, are not identified as risk factors by some authors ([@b6-cln_67p1053],[@b7-cln_67p1053]).

The frequency of DVT observed in TKA varies from 20.3% to 84%, regardless of prophylaxis. In the proximal form of DVT, these values range from 4.4% to 20% ([@b6-cln_67p1053],[@b27-cln_67p1053])--([@b30-cln_67p1053]). In our study, we observed only one case of clinical DVT, which made statistical analysis unfeasible. Although most studies report small numbers of patients with symptomatic DVT, Wang et al. ([@b28-cln_67p1053]) observed this clinical phenomenon in up to 70% of cases. There were no cases of pulmonary embolism in the present study. The frequency of pulmonary embolism has been reported to be low, varying between 0 and 20% ([@b31-cln_67p1053],[@b32-cln_67p1053]), but most studies have reported that the frequency is approximately 1% ([@b6-cln_67p1053],[@b33-cln_67p1053],[@b34-cln_67p1053]). In our analyses, we only considered cases of general DVT and proximal DVT, which were specifically studied because these forms are considered to potentially have more severe complications ([@b30-cln_67p1053],[@b35-cln_67p1053],[@b36-cln_67p1053]).

Data related to the surgical procedure itself are always important to orthopedists. The most optimal moment at which the surgical technique can be evaluated and modified for the patient\'s benefit is during the operation. The type of anesthesia used is certainly one of the most frequently evaluated topics in the literature, although some doubts remain regarding the effects of anesthesia type on DVT incidence. Researchers have studied epidural block alone versus general anesthesia, and most data suggest that epidural block should be protective against DVT ([@b29-cln_67p1053],[@b37-cln_67p1053])--([@b40-cln_67p1053]). However, in a recent article, Macfarlane et al. ([@b41-cln_67p1053]) questioned these results. Evaluating anesthesia in isolation was not the objective of our study. The high frequency of spinal blocks in the present study (96.9%) can be attributed to the routines of the anesthesia service. Thus, it was not possible to detect the influence of the type of anesthesia on the occurrence of DVT.

Wilson et al. ([@b42-cln_67p1053]) stated that traction of blood vessels, which are more constricted closer to the bone as a result of the tourniquet, increases the likelihood of blood vessel lesions. Wauke et al. ([@b43-cln_67p1053]) postulated that the use of tourniquets may be associated with the occurrence of DVT, although they did not present any concrete data to support this theory. In evaluating our data, we did not observe any significant results regarding the overall presence of DVT in relation to a longer tourniquet time.

In our analysis of patients with proximal DVT, we observed a higher likelihood of DVT with longer tourniquet times, but this association was not statistically significant (*p* = 0.08). This observation lends some support to the findings of Abdel-Salam and Eyres ([@b48-cln_67p1053]), who reported a greater number of patients with proximal DVT when tourniquets were used.

Total operative time was considered to be significantly associated with the incidence of proximal DVTs, which as mentioned earlier, are considered to be the more severe DVT type ([@b30-cln_67p1053],[@b35-cln_67p1053],[@b36-cln_67p1053]). A report by Stringer et al. ([@b2-cln_67p1053]) was the only report we found indicating that the total operative time is a risk factor, although it did not define the cutoff point for operative time. Our data enabled us to conclude that a total operative time of \>2 hours is correlated with a higher frequency of proximal DVT. The results of the analysis of these variables when considered as continuous categories for total operative time generated a *p*-value of 0.01, which further reinforces our findings.

Although this study has provided some interesting findings, it also has some limitations. We performed a case-control study, an observational study in which patients were selected on the basis of whether they have the disorder under study, in this case, DVT. Because this type of study does not involve direct experimentation or variable manipulation, the validity of the statistical association between exposure and disease must be made under conditions that are not strictly controlled ([@b49-cln_67p1053]). Therefore, *a priori* power analysis and sample size determination were not performed. We observed differences between the groups concerning age and diagnosis. Patients with DVT were older than patients without DVT. This observation lends some support to the findings of Markovic-Denic et al. ([@b50-cln_67p1053]), who reported that age is a significant risk factor for DVT. Considering only patients with proximal DVT, we found no difference between the groups. We believe that, for this subgroup of patients, a longer operative time is an important risk factor for DVT.

Despite our conviction concerning the link between operative time and DVT, which was confirmed by our findings, we do not recommended rushing the surgical procedure in an attempt to shorten it because other equally severe problems, such as poor component alignment, poor ligament balance, and unsatisfactory homeostasis, may develop. We believe that the most effective way to shorten surgery is detailed planning, discipline, and familiarization of the surgical team with the surgical instruments. We should note that our institution is a training center for large numbers of medical residents, who perform many TKAs.

We conclude that a total operative time of \>120 minutes, which is generally sufficient for a careful procedure in the majority of TKAs, increases the risk of proximal DVT, and although our findings were not statistically significant, a tourniquet time of \>90 minutes should be considered as a possible risk factor for proximal DVT.
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###### 

Patient baseline characteristics.

                 Population             Without DVT        With DVT           *p*-value        
  -------------- ---------------------- ------------------ ------------------ ---------------- ---------------------------------------------------
  Gender                                                                                       
  no. (%)        Male                   17 (21.8)          11 (24.4)          6 (18.2)         0.51
                 Female                 61 (78.2)          34 (75.6)          27 (81.8)        
  Age            Mean (range)           65.1 (31-88)       62.9 (31-88)       68.2(39-82)      0.04[\*](#tfn1-cln_67p1053){ref-type="table-fn"})
  Ethnic group                                                                                 
  no. (%)        White                  56 (71.8)          30 (66.7)          26 (78.8)        
                 Black                  14 (17.9)          11 (24.4)          3 (9.1)          0.21
                 Other                  8 (10.3)           4 (8.9)            4 (12.1)         
  Diagnosis                                                                                    
  no. (%)        Osteoarthritis         58 (74.4)          29 (64.4)          29 (87.9)        
                 Rheumatoid arthritis   17 (21.8)          14 (31.1)          3 (9.1)          0.05[\*](#tfn1-cln_67p1053){ref-type="table-fn"})
                 Other                  3 (3.8)            2 (4.4)            1 (3.0)          
  BMI            Mean (range)           29.2 (18.5-48.3)   29.2 (18.5-41.4)   29.3 (21-48.3)   0.95

significant *p*-value.

BMI - body mass index.

###### 

The population distribution based on tourniquet (n = 74) and operative times (n = 78) and a comparative analysis of patients with and without DVT.

  Variable                No. of Patients (%)   *p*-value               
  ----------------------- --------------------- ----------- ----------- ------
  Tourniquet time (min)                                                 
      \<60                6 (8.1)               3 (7.0)     3 (9.7)     0.19
      61--90              33 (44.6)             21 (48.8)   12 (38.7)   
      91--120             32 (43.2)             19 (44.2)   13 (41.9)   
      121--150            3 (4.1)               ---         3 (9.7)     
  Surgery time (min)                                                    
      \<120               24 (31.1)             16 (35.6)   8 (24.2)    0.56
      121--150            43 (53.8)             23 (51.1)   20 (60.6)   
      \>150               11 (14.1)             6 (13.3)    5 (15.2)    

Chi-squared test.

DVT, deep vein thrombosis.

###### 

The population distribution by tourniquet (n = 74) and operative times (n = 78) and a comparative analysis of patients with and without proximal DVT.

  Variable                No. of Patients (%)   *p*-value   
  ----------------------- --------------------- ----------- --------
  Tourniquet time (min)                                     
      \<60                5 (8.1)               1 (8.3)     0.08
      61--90              27 (43.5)             6 (50.0)    
      91--120             29 (46.8)             3 (25.0)    
      121--150            1 (1.6)               2 (16.7)    
  Surgery time (min)                                        
      \<120               23 (35.4)             1 (7.7)     0.05\*
      121--150            35 (53.8)             8 (61.5)    
      \>150               7 (10.8)              4 (30.8)    

Chi-squared test; \*significant value.

DVT, deep vein thrombosis.

###### 

Analysis of patients with proximal DVT and patients without proximal DVT by tourniquet (n = 74) and operative times (n = 78) and a comparison of means.

  Variable                No. of Patients (%)   *p*-value    
  ----------------------- --------------------- ------------ --------
  Tourniquet time (min)                                      
      μ±SD                88.7±18.5             94.9±22.6    0.31
      Range               45--125               44--130      
  Surgery time (min)                                         
      μ±SD                127.9±22.4            146.9±20.4   0.01\*
      Range               60--195               120--200     

Chi-squared test, \*significant value.

DVT, deep vein thrombosis; μ, mean; SD, standard deviation.
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